Capricor Therapeutics, Inc. (CAPR) Financials

CAPR Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 58.7 million 36.1 million
2023-09-30 37.2 million 38.9 million
2023-06-30 46.0 million 43.3 million
2023-03-31 53.9 million 47.7 million

CAPR Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -12.3 million 1.9 million
2023-09-30 -9.4 million 1.7 million
2023-06-30 -9.7 million 1.6 million
2023-03-31 3.8 million 2.2 million

CAPR Net Income

No data available :(

CAPR Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 39.5 million - 2.2 million
2023-09-30 28.5 million - 2.4 million
2023-06-30 37.8 million 3.4 million 2.2 million
2023-03-31 45.2 million 3.4 million 2.4 million

CAPR Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 30.7 million
2023-09-30 25.8 million
2023-06-30 25.3 million
2023-03-31 25.2 million

CAPR Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 729222 9.8 million 3.0 million 85056
2023-09-30 631753 10.0 million 3.0 million -
2023-06-30 233443 8.8 million 2.8 million -
2023-03-31 453115 7.7 million 3.5 million -

CAPR Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 12.1 million 307608
2023-09-30 6.2 million 276471
2023-06-30 3.9 million 248250
2023-03-31 3.0 million 7.7 million

CAPR

Price: $5.47

52 week price:
2.68
8.22

Earnings Per Share: -0.83 USD

P/E Ratio: -3.42

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 60100

Ebitda: -2.6 million

Market Capitalization: 184.6 million

Links: